Skip to main content

Elisabetta Varani, MD

Original Contribution
08/01/2008
Since the introduction of drug-eluting stents (DES) in clinical practice, it has become clear that percutaneous revascularization of multivessel coronary artery disease (CAD) could be more effective in terms of event reduction (major adverse...
Since the introduction of drug-eluting stents (DES) in clinical practice, it has become clear that percutaneous revascularization of multivessel coronary artery disease (CAD) could be more effective in terms of event reduction (major adverse...
Since the introduction of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
03/10/2009
From the Department of Cardiology, S. Maria delle Croci Hospital, Ravenna, Italy. The authors report no conflicts of interest regarding the content herein. Manuscript submitted August 7, 2008, provisional acceptance given December 2, 2008,...
From the Department of Cardiology, S. Maria delle Croci Hospital, Ravenna, Italy. The authors report no conflicts of interest regarding the content herein. Manuscript submitted August 7, 2008, provisional acceptance given December 2, 2008,...
From the Department of...
03/10/2009
Journal of Invasive Cardiology
Original Contribution
04/01/2013
To determine the adherence to the current recommendations, and the incidence of adverse events, we carried out the prospective, multi-center, observational WARfarin and coronary STENTing (WAR-STENT) registry. All consecutive patients on...
To determine the adherence to the current recommendations, and the incidence of adverse events, we carried out the prospective, multi-center, observational WARfarin and coronary STENTing (WAR-STENT) registry. All consecutive patients on...
To determine the adherence to...
04/01/2013
Journal of Invasive Cardiology